Therapeutic potential of phosphodiesterase inhibitors in the treatment of osteoporosis: Scopes for therapeutic repurposing and discovery of new oral osteoanabolic drugs-Reference-Cited by-同舟云学术

Therapeutic potential of phosphodiesterase inhibitors in the treatment of osteoporosis: Scopes for therapeutic repurposing and discovery of new oral osteoanabolic drugs

Published:2021-05 Issue: Volume:899 Page:174015
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Porwal Konica^ORCID,Pal Subhashis,Bhagwati Sudha,Siddiqi Mohd Imran,Chattopadhyay Naibedya

Funder

Council of Scientific & Industrial Research

Publisher

Elsevier BV

Subject

Pharmacology

Reference167 articles.

1. Glucocorticoid-induced osteoporosis: management update;Adler;Curr. Osteoporos. Rep.,2010

2. Inactivation of atrial natriuretic factor-stimulated cyclic guanosine 3’,5’-monophosphate (cGMP) in UMR-106 osteoblast-like cells;Ahlström;Biochem. Pharmacol.,2000

3. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation;Ahlström;Cell. Mol. Biol. Lett.,2005

4. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells;Ahlström;Biochem. Pharmacol.,2005

5. The effect of PDE5 inhibitors on bone and oxidative damage in ovariectomy-induced osteoporosis;Alp;Exp. Biol. Med.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of intracellular cAMP levels in osteocytes by mechano-sensitive focal adhesion kinase via PDE8A;2024-06-28

2. Investigating neuropathological changes and underlying neurobiological mechanisms in the early stages of primary blast-induced traumatic brain injury: Insights from a rat model;Experimental Neurology;2024-05

3. Quercetin potentiates the hepatoprotective effect of sildenafil and/or pentoxifylline against intrahepatic cholestasis: Role of Nrf2/ARE, TLR4/NF-κB, and NLRP3/IL-1β signaling pathways;Life Sciences;2023-02

4. Potential effects of teriparatide (PTH (1–34)) on osteoarthritis: a systematic review;Arthritis Research & Therapy;2023-01-06

5. Teriparatide ameliorates articular cartilage degradation and aberrant subchondral bone remodeling in DMM mice;Journal of Orthopaedic Translation;2023-01